Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II. 1991

J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
Department of Pathology, Stanford University School of Medicine, Palo Alto, CA.

Disease association studies of human T cell lymphotropic virus (HTLV) types I and II are hindered by the need for multiple assays to confirm and differentiate between the viruses. A modified Western blot assay has been developed using HTLV-I viral lysate and unique (MTA-4) and shared (p21E) HTLV recombinant proteins. By defining confirmation of infection as the presence of antibodies to p24 gag protein and to p21E, all 56 HTLV-I and 49 HTLV-II antisera were confirmed by this modified Western blot alone. Differentiation was determined by reactivity to MTA-4. All HTLV-I antisera reacted with MTA-4 and all HTLV-II antisera did not react with MTA-4. These findings indicate the utility of selected HTLV-I recombinant proteins in a single assay format to confirm and differentiate infections with HTLV-I and HTLV-II.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015367 Human T-lymphotropic virus 2 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 that can transform normal T-lymphocytes and can replicate in both T- and B-cell lines. The virus is related to but distinct from HTLV-1. HTLV-2,HTLV-II,Human T-Cell Leukemia Virus II,Human T-Lymphotropic Virus II,Leukemia Virus II, Human T-Cell,T-Cell Leukemia Virus II, Human,Human T Cell Leukemia Virus II,Human T Lymphotropic Virus II,Leukemia Virus II, Human T Cell,T Cell Leukemia Virus II, Human,Human T lymphotropic virus 2
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D015482 HTLV-II Antibodies Antibodies reactive with the HTLV-II ANTIGENS. Human T-Cell Leukemia Virus II Antibodies,Human T-Lymphotropic Virus II Antibodies,Leukemia-Lymphoma Virus II Antibodies, Human T-Cell,T-Cell Leukemia Virus II Antibodies, Human,HTLV II Antibodies,Human T Cell Leukemia Virus II Antibodies,Human T Lymphotropic Virus II Antibodies,Leukemia Lymphoma Virus II Antibodies, Human T Cell,T Cell Leukemia Virus II Antibodies, Human,Antibodies, HTLV II,Antibodies, HTLV-II,II Antibodies, HTLV
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015491 HTLV-II Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2. Human T-lymphotropic Virus 2 Infection,Human T-lymphotropic Virus 2 Infections,Infections, HTLV-II,HTLV-II Infection,Human T lymphotropic Virus 2 Infection,Human T lymphotropic Virus 2 Infections,Infection, HTLV-II,Infections, HTLV II

Related Publications

J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
January 1993, Transfusion,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
February 1993, Journal of clinical microbiology,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
June 1991, The Journal of infectious diseases,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
October 2004, Journal of medical virology,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
April 1993, The Western journal of medicine,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
February 2006, The Journal of infectious diseases,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
December 2019, Journal of clinical microbiology,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
January 1998, Virus genes,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
August 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
J J Lipka, and P Santiago, and L Chan, and G R Reyes, and K P Samuel, and W A Blattner, and G M Shaw, and C V Hanson, and J J Sninsky, and S K Foung
February 1997, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!